| A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma A Kumar, J Soumerai, JS Abramson, JA Barnes, P Caron, M Chabowska, ... Blood 142, 738, 2023 | 18 | 2023 |
| Long‐term follow‐up of multicenter phase ii trial of zanubrutinib, obinutuzumab, and venetoclax (BOVEN) in previously untreated patients with CLL/SLL JD Soumerai, A Dogan, V Seshan, K Flaherty, J Carter, E Hochberg, ... Hematological Oncology 41, 233-235, 2023 | 15 | 2023 |
| Review and meta-analysis for the caregiver's feeding styles questionnaire administered to low-income families BA Lopez, JS Nicholson, RN Garcia, HR Johnson, TG Power, SO Hughes Eating behaviors 46, 101659, 2022 | 9 | 2022 |
| A review of the Caregiver's Feeding Style Questionnaire (CFSQ): Differences in parent-child feeding styles across geographic location, caregiver roles, and Head Start samples H Johnson, B Lopez, R Garcia, JS Nicholson PhD | 1 | 2020 |
